English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Aids Institute
John Breslin
| Oct 27, 2017
CMS administrator urged to prevent states from restricting hepatitis C drug access
Nicholas Gueguen
| Aug 13, 2017
House Appropriations Committee decides to keep funding for several programs in HIV, hepatitis fight
Robert Hadley
| Jun 2, 2017
FDA approves higher once-a-day dose of Merck’s Isentress HIV drug
Erianne Leatherman
| May 16, 2017
AIDS Alliance working with Advocates for Youth to boost AIDS/HIV awareness
Erianne Leatherman
| Mar 15, 2017
Updates to National Viral Hepatitis Action Plan include strategies to prevent infection
Vimbai Chikomo
| Apr 6, 2016
Obamacare is failing to discipline Florida insurers for discriminating against hepatitis C patients, according to expert
Jamie Barrand
| Dec 24, 2015
The AIDS Institute officials laud rejection of HIV funding cuts
Katelyn Kivel
| Nov 3, 2015
Cigna leaves Florida exchange amid HIV discrimination allegations
Trending
+
Pharmaceuticals
Patient Daily
| Jul 22, 2025
Deputy VP of Public Affairs of PhRMA: 'It's time for Congress to fix the 340B Drug Pricing Program'
Patient Daily
| Jul 24, 2025
Long School of Medicine is largest physician trainer in South Texas
Patient Daily
| Jul 25, 2025
Healthcare CEO on 340B reform: ‘It’s the abuse by very large, very profitable, tax-exempt institutions that I think needs to change'
Patient Daily
| Jul 25, 2025
Balloon sinuplasty marks 20 years since FDA approval
